Boditech Med Inc
KOSDAQ:206640
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (12.4), the stock would be worth ₩11 979.42 (1% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 12.3 | ₩11 870 |
0%
|
| 3-Year Average | 12.4 | ₩11 979.42 |
+1%
|
| 5-Year Average | 11.2 | ₩10 835.22 |
-9%
|
| Industry Average | 14 | ₩13 603.86 |
+15%
|
| Country Average | 9 | ₩8 701.75 |
-27%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
B
|
Boditech Med Inc
KOSDAQ:206640
|
254.5B KRW | 12.3 | 9.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.2B USD | 56.5 | 60 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.3B USD | 16.5 | 25.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 24.8 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD | 14.7 | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92B USD | 20.3 | 25.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 13.2 | 18.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 30.6 | 44.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.1B USD | 38.2 | 42.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.3B USD | 12.8 | 24.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 16.7 | 21.6 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 4.2 |
| Median | 9 |
| 70th Percentile | 16.6 |
| Max | 2 215 132.4 |
Other Multiples
Boditech Med Inc
Glance View
Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2014-12-29. The firm is engaged in the manufacture and sale of antigen diagnostic kits and other products. In addition, the Company is engaged in the manufacture and sale of cancer diagnostic kit, drug concentration diagnostic kit and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 1998 and is located in Chuncheon-si, Gang-won-do, South Korea.
